Friday April 05, Paris

00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
SYMPOSIA
Meeting Room 342A
Patients' preferences for anti-osteoarthritis treatment: A cross-European Discrete Choice Experiment: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: Mickaël Hiligsmann, Elaine M. Dennison
08:00: Welcome and introduction Mickaël Hiligsmann
08:05: Identification prioritization of important attributes of OA treatment Elaine M. Dennison
08:20: Results from the cross-European discrete choice experiment Mickaël Hiligsmann
08:35: Discussion Elaine M. Dennison
08:55: Conclusion Mickaël Hiligsmann
Meeting Room 351
Osteosarcopenic obesity: enough evidence for a distinct entity: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculo-skeletal Health and Ageing
Chairpersons: Islene Araujo de Carvalho, Roger Fielding
08:00: Introduction Stefania Maggi
08:05: Osteosarcopenic obesity: Facts and evidence supporting a distinct entity Jürgen Bauer
08:20: Osteosarcopenic obesity: Lack of evidence supporting a distinct entity Alfonso Cruz Jentoft
08:35: Discussion Jürgen Bauer
08:55: Conclusion Roger Fielding
Panel: Islene Araujo de Carvalho, Jürgen Bauer, Olivier Bruyère, Roland D. Chapurlat, Cyrus Cooper, Alfonso Cruz Jentoft, Elaine M. Dennison, Roger Fielding, John A. Kanis, Jean‑Marc Kaufman, Francesco Landi, Andrea Laslop, Médéa Locquet, Stefania Maggi, Eugene McCloskey, Simone Perna, Jean‑Yves Reginster, René Rizzoli, Yves Rolland, Pawel Szulc
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting Room 341
What’s new in tendinopathies?
Chairperson: Jean‑François Kaux
Introduction Olivier Bruyère
Tendon physiopathology and imagery... What’s new ? Stijn Bogaerts
Rehabilitation: eccentric or not eccentric? Which physiotherapy? Jean‑Louis Croisier
Which efficacy for the new treatments ? Jean‑François Kaux
Meeting Room 352A
Real World Evidence in Metabolic Bone Disease
Chairperson: Daniel Prieto‑Alhambra
Real world data for assessing the use, risks, and benefits of anti-osteoporosis therapies in actual practice conditions Daniel Prieto‑Alhambra
Routinely collected data for the study of the epidemiology of fractures, and for characterising imminent fracture risk Bo Abrahamsen
Health economics using real world data: an introduction Rafael Pinedo‑Villanueva
Real world data for the study of orthopaedics and hip fracture care Alma Pedersen
Meeting Room 353
Emerging Biomarkers in Vitamin D Metabolism
Chairperson: Shaun Sabico
Biomarker Discovery Nasser Al‑Daghri
Vitamin D Biomarker Discovery Majed Alokail
Validation Yousef  Al‑Saleh
Meeting Room 343
Sarcopenia in older people: actual perspectives
Chairpersons: Nicola Veronese, Charlotte Beaudart
The radiological evaluation of muscle mass in older people Giuseppe Guglielmi
Physical performance in older people: actual evidence Olivier Bruyère
The diagnosis of sarcopenia in older people: between research and clinical practice Nicola Veronese
Meeting Room 342B
Female Bone Health: a gynecological approach through routine assistance
Chairperson: Adriana Orcesi Pedro
Opening: Women´s Hospital - CAISM - University of Campinas message for bone health Adriana Orcesi Pedro
Bone mass and fracture risk during pregnancy and lactation Anna V. Gueldini de Moraes, Fernanda Garanhani de Castro Surita
Update on management of osteoporosis in young women - special clinical situations Adriana Orcesi Pedro, Gabriela Pravatta Rezende
Evaluation and management of osteopenia and osteoporosis in breast cancer survivors Adriana Orcesi Pedro, Cesar Cabello dos Santos
Question & Answers with audience
09.00 - 10.30
Auditorium A
SCIENTIFIC SESSION I
Chairpersons: Jean‑Yves Reginster, John A. Kanis
09.00
Auditorium A
Plenary Lecture 1
‣ When and why use a bone forming agent?
Eugene McCloskey
09.30
Auditorium A
Oral communication selected from abstracts
09.30
Auditorium A
OC1
‣ HORMONE THERAPY REDUCES THE RISK OF FRACTURE IN FALLERS AND IN NON-FALLERS: RESULTS FROM THE WOMEN’S HEALTH INITIATIVE HORMONE THERAPY TRIALS
Presenting author: M. Lorentzon
Authors: H. Johansson, N. C. Harvey, E. Liu, J. Crandall, E. V. McCloskey, J. A. Kanis
09.40
Auditorium A
OC2
‣ ROMOSOZUMAB EFFICACY ON FRACTURE OUTCOMES IS GREATER IN PATIENTS AT HIGH BASELINE FRACTURE RISK: A POST HOC ANALYSIS OF THE FRAME STUDY
Presenting author: E. V. McCloskey
Authors: M. Lorentzon, H. Johansson, N. C. Harvey, J. A. Kanis
09.50
Auditorium A
OC3
‣ ROMOSOZUMAB ENHANCES 3D VERTEBRAL STRUCTURE IN WOMEN WITH LOW BONE DENSITY: MAPPING BONE GAINS AT ONE YEAR COMPARED WITH TERIPARATIDE OR PLACEBO
Presenting author: K. E. S. Poole
Authors: G. M. Treece, R. A. Pearson, A. H. Gee, M. A. Bolognese, J. P. Brown, S. Goemaere, A. Grauer, D. A. Hanley, C. Mautalen, C. Recknor, Y. C. Yang, C. Libanati, T. Whitmarsh
10.00
Auditorium A
OC4
‣ EFFECT OF ABALOPARATIDE ON BONE MINERAL DENSITY AND FRACTURE INCIDENCE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND OSTEOARTHRITIS
Presenting author: N. E. Lane
Authors: B. Mitlak, R. Weiss, Y. Wang, G. J. Valenzuela, J. P. Bilezikian
10.10
Auditorium A
OC5
‣ BUROSUMAB IMPROVES THE BIOCHEMICAL, SKELETAL, AND CLINICAL SYMPTOMS OF TUMOR-INDUCED OSTEOMALACIA (TIO) SYNDROME
Presenting author: S. Jan de Beur
Authors: P. Miller, T. Weber, M. Peacock, K. Insogna, R. Kumar, D. Luca, T. Cimms, K. Lampl, J. San Martin, T. Carpenter
10.20
Auditorium A
Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards
Jean‑Yves Reginster
10.30 - 12.10
Auditorium A
SCIENTIFIC SESSION II
Chairpersons: René Rizzoli, Cyrus Cooper
10.30
Auditorium A
Presentation of the ESCEO-IOF Herbert Fleisch Medal
René Rizzoli
10.40
Auditorium A
Plenary Lecture 2
‣ Bone fragility and its treatment in chronic renal failure
Peter R. Ebeling
11.10
Auditorium A
Presentation of the IOF President's Award
Cyrus Cooper
11.20
Auditorium A
Oral communication selected from abstracts
11.20
Auditorium A
OC6
‣ IMMINENT (1- AND 2-YEAR) FRACTURE RISK FOLLOWING A FIRST (SENTINEL) FRACTURE: A MULTINATIONAL EUROPEAN COHORT STUDY INCLUDING OVER 700,000 PARTICIPANTS FROM DENMARK, SPAIN, AND THE UK
Presenting author: D. Prieto‑Alhambra
Authors: S. Khalid, M. Thomsen Ernst, M. K. Javaid, C. Libanati, C. Cooper, A. Delmestri, D. Martinez‑Laguna, E. Toth, B. Abrahamsen
11.30
Auditorium A
OC7
‣ ADJUSTING FRAX FOR IMMINENT RISK
Presenting author: H. Johansson
Authors: K. Siggeirsdottir, N. C. Harvey, E. V. McCloskey, V. Gudnason, G. Sigurdsson, M. Lorentzon, E. Liu, J. A. Kanis
11.40
Auditorium A
OC8
‣ AGE AT HIP FRACTURE: TIME TRENDS OVER TWO DECADES IN A NATIONAL HOSPITAL DISCHARGE REGISTER
Presenting author: B. Abrahamsen
Authors: H. V. B. Laursen, M. K. Skjødt, M. H. Jensen, P. Vestergaard
11.50
Auditorium A
OC9
‣ T-SCORE AS AN INDICATOR OF FRACTURE RISK ON THERAPY: EVIDENCE FROM ROMOSOZUMAB VS. ALENDRONATE TREATMENT IN THE ACTIVE-CONTROLLED FRACTURE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AT HIGH RISK TRIAL
Presenting author: S. Ferrari
Authors: F. Cosman, E. M. Lewiecki, P. R. Ebeling, E. Hesse, N. Napoli, D. B. Crittenden, M. Rojeski, W. Yang, C. Libanati
12.00
Auditorium A
OC10
‣ FRACTURE INCIDENCE AFTER DENOSUMAB DISCONTINUATION: REAL-WORLD DATA FROM A LARGE HEALTHCARE PROVIDER
Presenting author: L. Tripto‑Shkolnik
Authors: N. Fund, V. Rouach, G. Chodick, V. Shalev, I. Goldshtein
13.45 - 14.00
Podium
IOF Calcium Academy Awards ceremony
Bess Dawson‑Hughes
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Meeting Room 341
How to assess frailty in daily practice ?
Evelien Gielen
Meeting Room 352A
Local therapies in osteoarthritis management
François Rannou
Meeting Room 353
Pre- and postnatal influences on bone and muscle health in children
Nicholas Harvey
Meeting Room 343
Strengths of recommendations for GIOP management
Jonathan Adachi
Meeting Room 342B
New algorithm for the management of bone fragility in diabetes
Serge Ferrari
14.00 - 15.00
SYMPOSIA
Meeting Room 342A
Reassessment of the safety of anti-osteoarthritis medications: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: Olivier Bruyère, Elaine M. Dennison
14:00: Welcome and scope of the problem Cyrus Cooper
14:05: Methodology of the ESCEO Working Group Cyrus Cooper
14:15: Safety of analgesics, non-steroidal anti-inflammatory drugs and opioids Nicholas R. Fuggle
14:30: Safety of SYSADOAs, intraarticular Hyaluronic Acid and intraarticular corticosteroids Tim McAlindon
14:45: Discussion Nigel K. Arden
14:55: Wrap-up and conclusions Nigel K. Arden
Meeting Room 351
Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: outcomes of an ESCEO-IOF experts consensus meeting organized under the auspices of the WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging
Chairpersons: Adolfo Diez‑Perez, Stefania Maggi
14:00: Welcome and scope of the problem Maria Luisa Brandi
14:05: Determinants of non-adherence to anti-osteoporosis medications Bernard Vrijens
14:20: Recommendations to improve adherence to anti-osteoporosis medications Mickaël Hiligsmann
14:35: Recommendations for additional research needed to improve adherence to anti-osteoporosis medications Bo Abrahamsen
14:45: Discussion (Leader : Sansin Tuzun)
15:00: Closure of the meeting Adolfo Diez‑Perez
14.00 - 15.00
Poster Area
Poster Viewing Session I
14.00 - 15.10
Podium
Oral presentation of selected posters
Chairperson: Tara Brennan‑Speranza
14.00
Podium
P893
‣ IDENTIFICATION OF PATIENTS AT HIGH RISK FOR OSTEOPOROTIC FRACTURES THROUGH RADIOFREQUENCY ECHOGRAPHIC MULTI SPECTROMETRY (REMS): RESULTS OF A 5-YEAR FOLLOW-UP STUDY
Presenting author: C. Caffarelli
Authors: S. Gonnelli, G. Bianchi, M. L. Brandi, S. Casciaro, L. Cavalli, L. Cianferotti, F. Conversano, A. Fassio, G. Girasole, A. Grimaldi, F. A. Lombardi, M. Muratore, P. Pisani, L. Quarta, D. Gatti
14.07
Podium
P927
‣ PATIENT AND SERVICE-LEVEL PREDICTORS OF BONE TREATMENT RECOMMENDATION POST-FRACTURE: RESULTS FROM THE UK NATIONAL FRACTURE LIAISON SERVICE (FLS) DATABASE
Presenting author: M. K. Javaid
Authors: S. Hawley, N. Vasilakis, B. Wiles, C. L. Gregson, N. Gittoes, G. Clunie, C. Cockill, I. Price, A. Judge, A. Smith
14.14
Podium
P363
‣ FRAILTY IN OLDER COMMUNITY DWELLING ADULTS: A COMPARATIVE STUDY OF THE UK AND JAPAN
Presenting author: N. Yoshimura
Authors: E. M. Dennison, K. A. Jameson, S. Tanaka, T. Iidaka, C. Cooper
14.21
Podium
P154
‣ EWGSOP 2 VERSUS EWGSOP 1: IMPACT ON THE PREVALENCE OF SARCOPENIA AND ITS OUTCOMES
Presenting author: M. Locquet
Authors: C. Beaudart, J. Petermans, O. Bruyère
14.28
Podium
P639
‣ DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS IS A NEW RISK FACTOR FOR VERTEBRAL FRACTURE IN OLDER MEN – THE PROSPECTIVE MINOS STUDY
Presenting author: P.  Szulc
Authors: A. Guiot, R. D. Chapurlat
14.35
Podium
P837
‣ FOR ALL PRACTITIONERS AND RESEARCHERS TO ASSESS HAND DYSFUNCTION IN HAND OSTEOARTHRITIS (OA): THE QUICK, FRIENDLY AND AVAILABLE FOR FREE FUNCTIONAL INDEX FOR HAND OA WEBSITE FIHOA.NET
Presenting author: E. Maheu
Author: R.‑L. Dreiser
14.42
Podium
P586
‣ IMMINENT FRACTURE RISK AMONGST NEW USERS OF ORAL BISPHOSPHONATES IN ACTUAL PRACTICE SETTINGS: A MULTI-NATIONAL EUROPEAN COHORT STUDY FROM DENMARK, SPAIN, AND THE UK
Presenting author: D. Prieto‑Alhambra
Authors: S. Khalid, M. Thomsen Ernst, M. K. Javaid, C. Libanati, C. Cooper, A. Delmestri, D. Martinez‑Laguna, E. Toth, B. Abrahamsen
14.49
Podium
P701
‣ RISK OF HAND OSTEOARTHRITIS IN NEW USERS OF HORMONE REPLACEMENT THERAPY: A NESTED CASE-CONTROL ANALYSIS
Presenting author: T. Burkard
Authors: M. Rauch, J. Spoendlin, D. Prieto‑Alhambra, S. S. Jick, C. R. Meier
14.56
Podium
P1041
‣ CAN WE AVOID THE LOSS OF BONE MINERAL DENSITY ONE YEAR AFTER DENOSUMAB DISCONTINUATION? THE REOLAUS BONE PROJECT
Presenting author: B. Aubry‑Rozier
Authors: G. Liebich, D. Stoll, E. Gonzalez‑Rodriguez, D. Hans, O. Lamy
15.03
Podium
P698
‣ MAJOR OSTEOPOROTIC FRACTURE RISK FOLLOWING BARIATRIC SURGERY: A SELF-CONTROLLED CASE SERIES INCLUDING 5,492 PEOPLE FROM THE UK CPRD AND LINKED HES DATABASES
Presenting author: D. E. Robinson
Authors: I. Douglas, G. D. Tan, C. Cooper, A. Delmestri, M. K. Javaid, A. Judge, V. Y. Strauss, D. Prieto‑Alhambra
15.00 - 17.00
Auditorium A
SCIENTIFIC SESSION III
Chairpersons: Charlotte Beaudart, Bess Dawson‑Hughes
15.00
Auditorium A
Plenary Lecture 3
‣ Early treatment of osteoarthritis
Nigel K. Arden
15.30
Auditorium A
Oral communication selected from abstracts
15.30
Auditorium A
OC11
‣ CARDIOVASCULAR COMORBIDITIES HAS A DELETERIOUS INFLUENCE ON KNEE OA PROGNOSIS AT 5 YEARS: DATA FROM THE PROSPECTIVE KHOALA COHORT
Presenting author: C. Roubille
Authors: J. Joel, S. Sellam, A. C. Rat, F.  Guillemin, C. Roux
15.40
Auditorium A
OC12
‣ PREVALENCE OF SARCOPENIA ACCORDING TO THE REVISED EWGSOP DEFINITION AND ITS ASSOCIATIONS WITH BONE STRUCTURE AND INCIDENT FALLS IN SWEDISH OLDER ADULTS
Presenting author: D. Scott
Authors: J. Johansson, L. Mcmillan, P. R. Ebeling, P. Nordstrom, A. Nordstrom
15.50
Auditorium A
OC13
‣ STRENGTH AND PERFORMANCE-BASED OPERATIONAL MEASURES OF SARCOPENIA: PREVALENCE AND ASSOCIATIONS WITH SOCIAL FACTORS AND PHYSICAL DISABILITY IN 10,461 ADULTS AGED 65 YEARS AND OVER FROM SIX LOWER- AND MIDDLE-INCOME COUNTRIES
Presenting author: S. L. Brennan‑Olsen
Authors: S. J. Bowe, P. Kowal, J. Gaskin, N. Naidoo, J. Snodgrass, T. Quashie, S. Agrawal, G. Eick, C. D'Este
16.00
Auditorium A
OC14
‣ WHICH MUSCLE PARAMETERS ARE LONGITUDINALLY ASSOCIATED WITH FUTURE KNEE OSTEOARTHRITIS OUTCOMES? FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author: N. R. Fuggle
Authors: L. D. Westbury, K. A. Jameson, H. E. Syddall, M. H. Edwards, K. A. Ward, E. M. Dennison, C. Cooper
16.10
Auditorium A
OC15
‣ PATIENT ENGAGEMENT IN CLINICAL GUIDELINES DEVELOPMENT: INPUT FROM >1000 MEMBERS OF THE CANADIAN OSTEOPOROSIS PATIENT NETWORK
Presenting author: L. Funnell
Authors: M. Djekic‑Ivankovic, R. Chepesiuk, L. Giangregorio, I. Braganca Rodrigues, R. Ridout, S. Feldman, S. Kim, H. Mcdonald‑Blumer, G. Kline, W. E. Ward, N. Santesso, W. D. Leslie, S. N. Morin
16.20
Auditorium A
OC16
‣ RISK OF MAJOR OSTEOPOROTIC FRACTURE AFTER BARIATRIC SURGERY IN FRANCE: POPULATION BASED, RETROSPECTIVE COHORT STUDY
Presenting author: J. Paccou
Authors: N. Martignène, E. Lespessailles, G. Babykina, B. Cortet, G. Ficheur
16.30
Auditorium A
Plenary Lecture 4
‣ Guidelines for the management of osteoarthritis
Jean‑Yves Reginster
15.00 - 16.45
Meeting Room 351
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
‣ Clinical, social, ethical and economic burden of osteoporosis and fragility fractures
Chairpersons: Jean‑Yves Reginster, Famida Jiwa, Philippe Halbout
15.03
Meeting Room 351
OCs1
‣ DETERMINANTS AND HEALTH CONSEQUENCES OF A RAPID MUSCLE HEALTH DECLINE IN OLDER ADULTS FROM THE SARCOPHAGE STUDY
Presenting author: M. Locquet
Authors: C. Beaudart, J.‑L. Croisier, J.‑Y. Reginster, O. Bruyère
15.11
Meeting Room 351
OCs2
‣ THE ASSOCIATION BETWEEN RESTING METABOLIC RATE (RMR) AND SARCOPENIC OBESITY (SO) IN OVERWEIGHT AND OBESE ADULT WOMEN
Presenting author: K. Mirzaei
Authors: N. Rasaei, S. F. Sajjadi, S. A. Keshavarz
15.19
Meeting Room 351
OCs3
‣ WILL THERE BE A FRACTURE IN THEIR FUTURE? BONE MINERAL DENSITY FINDINGS IN YOUNG SOUTH EAST ASIAN WOMEN WITH ANOREXIA NERVOSA
Presenting author: M. Chandran
Author: Y. Hao
15.27
Meeting Room 351
OCs4
‣ THE BENEFITS OF REGULAR WEIGHT BEARING ACTIVITY THROUGHOUT THE LIFE-COURSE: DO MEN AND WOMEN REAP THE SAME REWARDS?
Presenting author: J. Zhang
Authors: M. A. Clynes, K. A. Jameson, C. Cooper, E. M. Dennison
15.35
Meeting Room 351
OCs5
‣ ASSOCIATION OF 25-HYDROXY VITAMIN D WITH BONE TURNOVER MARKERS AND BONE MINERAL DENSITY IN AN IRANIAN ELDERLY POPULATION: BUSHEHR ELDERLY HEALTH (BEH) PROGRAM
Presenting author: S. Gharibzadeh
Authors: N. Fahimfar, G. Shafiee, R. Heshmat, N. Mehrdad, F. Razi, P. Khashayar, A. Raiesi, I. Nabipour, B. Larijani, A. Ostovar
15.45
Meeting Room 351
Presentation of the IOF Committee of National Societies Medal
Jean‑Yves Reginster
15.55
Meeting Room 351
OCs6
‣ SERUM VITAMIN D LEVEL ASSOCIATED WITH COGNITIVE AND PHYSICAL FUNCTIONING OF POSTMENOPAUSAL WOMEN
Presenting author: A. A. Popov
Authors: N. V. Izmozherova, E. A. Safianik, A. A. Vikhareva, V. M. Bakhtin, M. A. Shambatov
16.03
Meeting Room 351
OCs7
‣ POSTPARTUM OSTEOPOROSIS ASSOCIATED WITH VERTEBRAL FRACTURES
Presenting author: N. Temelkova
Authors: A. Gerganova, K. Temelkova, K. Sirakova, P. Popivanov
16.11
Meeting Room 351
OCs8
‣ VALIDATION OF THE FRACTURE RISK ASSESSMENT TOOL (FRAX) CALCULATOR IN TAIWAN-TWO COHORTS STUDY
Presenting author: C. H. Wu
Authors: F. W. Liang, I. T. Liu, Y. F. Chang, L. C. Ou, C. S. Chang, T. H. Lu
16.19
Meeting Room 351
OCs9
‣ PREVALENCE OF SARCOPENIA IN INDIAN MEN AND WOMEN VARIES ACCORDING TO THE DEFINITION USED
Presenting author: A. Zengin
Authors: B. Kulkarni, A. V. Khadilkar, V. Ekbote, N. Kajale, N. Tandon, S. K. Bhargava, H. P. S. Sachdev, S. Sinha, C. H. D. Fall, P. R. Ebeling
16.27
Meeting Room 351
OCs10
‣ VERTEBRAL PAIN AND PHYSICAL PERFORMANCE INDICES IN POSTMENOPAUSAL WOMEN WITH VERTEBRAL FRACTURES DEPENDING ON BONE MINERAL DENSITY PARAMETERS
Presenting author: N. Grygorieva
Authors: V. Povoroznyuk, O. Rybina
16.35
Meeting Room 351
OCs11
‣ FAMILY HISTORY INFLUENCES FRACTURE RISK BMD- INDEPENDENTLY
Presenting author: A. I. Gasparik
Authors: M. L. Cevei, D. Stoicanescu, T. Szocs